Cargando…
Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204938/ https://www.ncbi.nlm.nih.gov/pubmed/29618493 http://dx.doi.org/10.1136/jnnp-2017-317509 |
_version_ | 1783366114363834368 |
---|---|
author | Cerqueira, João J Compston, D Alastair S Geraldes, Ruth Rosa, Mario M Schmierer, Klaus Thompson, Alan Tinelli, Michela Palace, Jacqueline |
author_facet | Cerqueira, João J Compston, D Alastair S Geraldes, Ruth Rosa, Mario M Schmierer, Klaus Thompson, Alan Tinelli, Michela Palace, Jacqueline |
author_sort | Cerqueira, João J |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6204938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-62049382018-10-30 Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? Cerqueira, João J Compston, D Alastair S Geraldes, Ruth Rosa, Mario M Schmierer, Klaus Thompson, Alan Tinelli, Michela Palace, Jacqueline J Neurol Neurosurg Psychiatry Multiple Sclerosis BMJ Publishing Group 2018-08 2018-04-04 /pmc/articles/PMC6204938/ /pubmed/29618493 http://dx.doi.org/10.1136/jnnp-2017-317509 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Multiple Sclerosis Cerqueira, João J Compston, D Alastair S Geraldes, Ruth Rosa, Mario M Schmierer, Klaus Thompson, Alan Tinelli, Michela Palace, Jacqueline Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? |
title | Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? |
title_full | Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? |
title_fullStr | Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? |
title_full_unstemmed | Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? |
title_short | Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? |
title_sort | time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? |
topic | Multiple Sclerosis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204938/ https://www.ncbi.nlm.nih.gov/pubmed/29618493 http://dx.doi.org/10.1136/jnnp-2017-317509 |
work_keys_str_mv | AT cerqueirajoaoj timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis AT compstondalastairs timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis AT geraldesruth timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis AT rosamariom timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis AT schmiererklaus timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis AT thompsonalan timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis AT tinellimichela timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis AT palacejacqueline timemattersinmultiplesclerosiscanearlytreatmentandlongtermfollowupensureeveryonebenefitsfromthelatestadvancesinmultiplesclerosis |